Atideb Mitra
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 2
- Genetics 7
- Genetic Associations and Epidemiology 7
Atideb Mitra
16 papers receiving 2.8k citations
Atideb Mitra's Hit Papers
Peers
Comparison fields: 5 of 107
- Infectious Diseases 1.8k
- Genetics 529
- Applied Microbiology and Biotechnology 35
- Emergency Medical Services 79
- Internal Medicine 28
Countries citing papers authored by Atideb Mitra
This map shows the geographic impact of Atideb Mitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atideb Mitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atideb Mitra more than expected).
Fields of papers citing papers by Atideb Mitra
This network shows the impact of papers produced by Atideb Mitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atideb Mitra. The network helps show where Atideb Mitra may publish in the future.
Co-authors
The 1 scholars most cited alongside Atideb Mitra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 7 | 2021 | 213 | |
| 8 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 9 | 2017 | 112 | |
| 10 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 11 | 2023 | 60 | |
| 12 | 2019 | 28 | |
| 13 | 2021 | 26 | |
| 14 | 2019 | 20 | |
| 15 | 2024 | 8 | |
| 16 | 2003 | 1 | |
| 17 | 2021 | 0 |
About Atideb Mitra
Atideb Mitra is a scholar working on Infectious Diseases, Genetics, Emergency Medical Services, Emergency Medicine and Health Information Management, having authored 17 papers that have together received 2.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Genetic Associations and Epidemiology (7 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Emergency and Acute Care Studies (1 paper), Global Health and Surgery (1 paper), Delphi Technique in Research (1 paper), Patient Safety and Medication Errors (1 paper) and Cardiovascular and Diving-Related Complications (1 paper). The work is most often cited by research in Infectious Diseases (1.8k citations), Genetics (529 citations), Applied Microbiology and Biotechnology (35 citations), Emergency Medical Services (79 citations) and Internal Medicine (28 citations). Atideb Mitra has collaborated with scholars based in United Kingdom, New Zealand and Vietnam. Frequent co-authors include Vikas Kohli. Their work appears in journals such as The Lancet, Nature, British Journal of Anaesthesia, Human Genetics and Genomics Advances and British journal of surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.